Publicly Traded and Startup Cannabis Financial News for the Week Ending July 22nd, 2022
July 18th
MedMen (OTC: MMNFF) Was Sued For Almost $1 Million In Back Rent.
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced the first commercial export to Israel of high THC Flower for medical use.
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF), published its financial results for the quarter ended May 31, 2022.
July 19th
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced the first commercial export to Israel of high THC Flower for medical use.
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF), published its financial results for the quarter ended May 31, 2022.
July 19th
Cannabis firm Alleaves raises $40 million for multi-state roll-out of seed-to-sale technology.
High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) entered an agreement with Echelon Wealth Partners Inc.
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced closure of its previously announced exchange transaction of certain 4.25% unsecured notes due 2023.
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) announced its financial and operating results for Q1 of 2022, with $1.16 million of revenue in Q1 2022
ZYUS Life Sciences Inc. has completed its first international shipment of ZYUS’ first-generation cannabinoid oil formulations to the Australian medical cannabis market.
July 20th
Pink Market Capital Research examined how Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) has managed to rake in more revenue during the past year than its competitors.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) entered into an intellectual property licensing & royalty agreement with Ei.Ventures, Inc.
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) launched Heritage Helps, a new program that combines initiatives that support the environment and communities in which it operates.
July 21st
Zelira Therapeutics (ASX: ZLD,OTC-QB: ZLDAF) announced that its insomnia medication Zenivol™ achieved formal approval from German regulatory authority BfArM.
Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) reported revenue in excess of USD$1.5MM and increased net assets from USD$2.1MM in 2020 to USD$10MM.
Zynerba Pharmaceuticals (Nasdaq: ZYNE) seals $20 million equity deal with a capital fund.
Metrc reaches an agreement with Rhode Island for medical cannabis regulation.
Comments
Post a Comment